Effect of repeated treatment with pyridostigmine on acetylcholinesterase in mouse muscles

Human & Experimental Toxicology

Volumn 16, Issue 3, 1997, Pages 158-165

  Lintern, M C ^a   Smith, M E ^a   Ferry, C B ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

acetylcholinesterase; anticholinesterase; muscle; neuromuscular junction; pyridostigmine

Indexed keywords

ACETYLCHOLINESTERASE; PYRIDOSTIGMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAPHRAGM MUSCLE; DRUG SENSITIVITY; ENZYME ACTIVITY; EXTENSOR DIGITORUM LONGUS MUSCLE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLEUS MUSCLE; SUBCUTANEOUS DRUG ADMINISTRATION;

ACETYLCHOLINESTERASE; ANALYSIS OF VARIANCE; ANIMALS; BETA-GALACTOSIDASE; CALIBRATION; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, SUBCUTANEOUS; MALE; MICE; MUSCLE, SKELETAL; PYRIDOSTIGMINE BROMIDE;

ANIMALIA;

EID: 0030985782     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719701600305     Document Type: Article

References (29)

1. Schwartz MS, Sargeant MK, Swash M. Neostigmine induced endplate proliferation in the rat. Neurology 1977; 27: 289-93.
2. Dirnhuber P., et al. The protection of primates against soman poisoning by pretreatment with pyridostigmine. Journal of Pharmacy and Pharmacology 1979; 31: 295-9.
3. Summers WK, et al. Tacrine as a treatment for Alzheimer's dementia - response. New England Journal of Medicine 1986; 315: 1241-8.
4. Trojan DA, Cashman NR Anticholinesterases in post-poliomyelitis syndrome In ‘The post-polio Syndrome’ Advances in the pathogenesis and treatment. Annals of the New York Academy of Sciences 1995; 753: 285-95.
5. Stephens R., et al. Neuropsychological effects of long-term exposure to organophosphates in sheep dip. Lancet 1995; 345: 1135 -9.
6. Massoulie J., Rieger F. L'acetylcholinesterase des organes electriques de poissons (torpille et gymnote); complexes membranaires. European Journal of Biochemistry 1969; 11: 441 -55.
7. Brockman SK, Usiak MF, Younkin SG Assembly of monomeric AChE into tetrameric assymmetric forms. Journal of Biological Chemistry 1986; 261: 1201-7.
8. Massoulie J., Bon S. The molecular forms of cholinesterase and acetylcholinesterase in vertebrates. Annual Review of Neuroscience 1982; 5: 57-106.
9. Taylor P. The cholinesterases. Journal of Biological Chemistry 1991; 266: 4025 -8.
10. Busker RW, Zijlstra JJ, Van der Wiel HJ, Van Helden Hpm. The functional role of molecular forms of acetylcholinesterase in neuromuscular transmission. Neurochemical Research 1994; 19: 713-9.
11. Lintern MC, Smith ME, Ferry CB Effects of pyridostigmine on acetylcholinesterase in different muscles of the mouse. Human and Experimental Toxicology 1996; 16: 18 - 24.
12. Lintern MC, Smith ME, Ferry CB The effect of repeated treatment with pyridostigmine on the activity of acetylcholinesterase molecular forms in mouse skeletal muscle. British Journal of Pharmacology 1995; 116: 81P.
13. Kuby SA, Lardy HA Purification and kinetics of β-D-galactosidase from Eschericia coli. Journal of American Chemical Society 1953; 75: 890-6.
14. Vallee BL, Hoch FL Zinc, a component of yeast alcohol dehydrogenase. Proceedings of the National Academy of Science, USA. 1955; 41: 327-38.
15. Johnson CD, Russell RL A rapid and simple radiometric assay for cholinesterase, suitable for multiple determinations. Analytical Biochemistry 1975; 64: 229-38.
16. Maxwell DM, Brecht KM, Doctor BP, Wolfe AD Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase. Journal of Pharmacology and Experimental Therapeutics 1989; 264: 1085-9.
17. Chiappa S. et al. Slow accumulation of acetylcholinesterase in rat brain during enzyme inhibition by repeated dosing with chlorpyrifos. Biochemical Pharmacology 1995; 49: 955-63.
18. Li Y., et al. Gene structure of mammalian acetylcholinesterase gene. Journal of Biological Chemistry 1991; 266: 23083-90.
19. Schumacher M., Maulet Y., Camp S., Taylor P. Multiple messenger RNA species give rise to the structural diversity in AChE. Journal of Biological Chemistry 1988; 263: 18979-87.
20. Goodwin BC, Sizer IW Effects of spinal cord and substrate on acetylcholinesterase in chick embryonic skeletal muscle. Developmental Biology 1965; 11: 136 - 53.
21. Fernandez HL, Hodgessavola CA Trophic regulation of acetylcholinesterase isozymes in adult mammalian skeletal muscles. Neurochemical Research 1992; 17: 115 - 24.
22. Amos ML, Smith ME, Ferry CB The effect of pyridostigmine bromide administration in mice on the expression of POMC-derived peptides in motoneurones. Journal of Physiology 1996; 491.P: 146P.
23. Amos ML, Smith ME, Ferry CB Effect of anticholinesterase treatment on the expression of pro-opiomelanocortin in motoneurones. Brain Research Association Abstracts 1995; 12: 76.
24. Haynes LW, Smith ME, Smyth DG Evidence for the neurotrophic regulation of acetylcholinesterase in immature skeletal muscle by β-endorphin. Journal of Neurochemistry 1984; 42: 1542-51.
25. Haynes LW, Smith ME Induction of endplate-specific acetylcholinesterase by β-endorphin C-terminal dipeptide in rat and chick muscle cells. Biochemical Society Transactions 1985; 13: 174- 5.
26. Hughes S., Smith ME Opioid receptors in muscle of normal and dystrophic mice. Neuroscience Letters 1990; 116: 29-33.
27. Padykula HA, Gautier GF The ultrastructure of the neuromuscular junctions of mammalian red, white and intermediate muscle fibres. Journal of Cell Biology 1970; 46: 27-41.
28. Smith AP Long term effects of the anticholinesterases sarin and soman on latencies of muscle action potentials in mouse diaphragm muscles. Journal of Pharmacy and Pharmacology 1993; 45: 176 - 81.
29. Kelly SS, Mutch E., Williams FM, Blain PG Electrophysiological and biochemical effects following single doses of organophosphates in the mouse. Archives of Toxicology 1994; 68: 459-66.